<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02063984</url>
  </required_header>
  <id_info>
    <org_study_id>DA015186-DartmouthSpectrum</org_study_id>
    <secondary_id>R01DA015186-12A1</secondary_id>
    <nct_id>NCT02063984</nct_id>
  </id_info>
  <brief_title>Behavioral Treatment of Adolescent Substance Use</brief_title>
  <acronym>SMART</acronym>
  <official_title>Behavioral Treatment of Adolescent Marijuana Use</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dartmouth-Hitchcock Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mountain Manor Treatment Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Spectrum Youth and Family Services</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Dartmouth-Hitchcock Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will continue research designed to improve treatment outcomes for adolescent&#xD;
      substance use disorders by integrating neuroscience- and behaviorally-based treatments. In&#xD;
      particular, this project will be the first to evaluate whether Working Memory Training can&#xD;
      enhance cognitive function and reduce impulsive decision making to improve abstinence&#xD;
      outcomes. In addition, an adaptive abstinence-based incentive program will be evaluated as a&#xD;
      new method for intervening with those who do not respond to their first-line treatment.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will test two novel strategies to enhance outcomes. Working Memory Training (WMT),&#xD;
      an efficacious method for strengthening specific cognitive processes, aims to improve factors&#xD;
      (e.g., delay discounting / impulsive decision-making) that have shown a strong relation to&#xD;
      substance use and treatment response. Second, more intensive and higher magnitude CM (ICM)&#xD;
      will be used to motivate abstinence among teens who are not abstinent by Week 4. The&#xD;
      investigators hypothesize that these strategies will improve outcomes by modifying a&#xD;
      fundamental cognitive system involved in making choices to engage in risky behavior and by&#xD;
      increasing motivation to abstain in early nonresponders. Aim 1 will pilot and refine the new&#xD;
      procedures in a community clinic in preparation for the randomized trial. A sequential,&#xD;
      multiple assignment randomized trial (SMART) will allow the study to determine the most&#xD;
      effective first-line treatment and the most effective adaptive strategy (Aim 2). All teens&#xD;
      will begin treatment with CM or CM/WMT. After 4 weeks, responders will continue in their&#xD;
      first-line treatments, while nonresponders will be randomized to ICM or to continue with&#xD;
      first-line treatment. Aim 3 will conduct mechanistic analyses to assess whether cognitive&#xD;
      changes related to WMT engender increased abstinence, and whether specific tailoring&#xD;
      variables moderate treatment effects. Aim 4 will gather formative data on implementation&#xD;
      factors to inform future large-scale studies and dissemination efforts. Primary hypotheses&#xD;
      are: (1) first-line treatment with WMT will improve abstinence outcomes and reduce relapse;&#xD;
      (2) strategies with ICM for nonresponders will result in better outcomes than those without;&#xD;
      (3) WMT will reduce delay discounting, which will predict outcome. The unique approach holds&#xD;
      promise for reducing multiple types of risky behaviors by affecting basic mechanisms that&#xD;
      determine impulsive decision-making.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 2013</start_date>
  <completion_date type="Actual">August 14, 2018</completion_date>
  <primary_completion_date type="Actual">February 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Any Cannabis Abstinence</measure>
    <time_frame>Intervention weeks 1 to 14</time_frame>
    <description>Number of participants with any cannabis abstinence during treatment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Weeks of Continuous Cannabis Abstinence</measure>
    <time_frame>14 week treatment period</time_frame>
    <description>Weeks of continuous abstinence during treatment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Any Days of Cannabis Use</measure>
    <time_frame>Intervention weeks 1 to 14</time_frame>
    <description>Number of participants with any days of cannabis use during treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days of Cannabis Use</measure>
    <time_frame>The intervention period between Week 1 and Week 14</time_frame>
    <description>Percent of Days Used During the Treatment Period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Any Cannabis Abstinence Across Four Treatment Strategies</measure>
    <time_frame>Treatment period between week 1 and week 14</time_frame>
    <description>Number of participants who achieved at least one week of abstinence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weeks of Cannabis Abstinence Across Four Treatment Strategies</measure>
    <time_frame>Treatment period between week 1 and week 14</time_frame>
    <description>Mean weeks of continuous cannabis abstinence among those who achieved at least one week of abstinence</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">59</enrollment>
  <condition>Substance Use Disorders</condition>
  <arm_group>
    <arm_group_label>Intensive Outpatient Treatment (IOP) + Contingency Management (CM) + Working Memory Training (WMT)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>IOP + CM + WMT</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IOP + CM</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>IOP + CM</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Intensive Outpatient Treatment (IOP) + Contingency Management (CM)</intervention_name>
    <description>Multiple group sessions weekly, one individual counseling session weekly with teen to review and discuss contingency management abstinence-based incentives</description>
    <arm_group_label>IOP + CM</arm_group_label>
    <arm_group_label>Intensive Outpatient Treatment (IOP) + Contingency Management (CM) + Working Memory Training (WMT)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Working Memory Training</intervention_name>
    <description>25 computer-delivered sessions of neurocognitive training</description>
    <arm_group_label>Intensive Outpatient Treatment (IOP) + Contingency Management (CM) + Working Memory Training (WMT)</arm_group_label>
    <other_name>Cogmed, Inc</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Participants must be 12 to 26 years of age, must live at home with the parent who will&#xD;
        participate, report using marijuana during the previous 30 days or provide a&#xD;
        marijuana-positive urine test, meet criteria for cannabis abuse or dependence, and have a&#xD;
        parent who can participate.&#xD;
&#xD;
        Exclusion Criteria: DSM criteria for dependence (likely to be adjusted for DSM-5 Use&#xD;
        Disorder) on alcohol or other drugs other than marijuana (use of or meeting criteria for&#xD;
        abuse of other substances will not be an exclusion criterion), active psychosis, severe&#xD;
        medical or psychiatric illness limiting participation, or pregnant or breast-feeding.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>26 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alan J Budney, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dartmouth College</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mountain Manor Treatment Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Stanger C, Scherer EA, Vo HT, Babbin SF, Knapp AA, McKay JR, Budney AJ. Working memory training and high magnitude incentives for youth cannabis use: A SMART pilot trial. Psychol Addict Behav. 2020 Feb;34(1):31-39. doi: 10.1037/adb0000480. Epub 2019 Jun 27.</citation>
    <PMID>31246068</PMID>
  </results_reference>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>February 13, 2014</study_first_submitted>
  <study_first_submitted_qc>February 13, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 17, 2014</study_first_posted>
  <results_first_submitted>April 14, 2021</results_first_submitted>
  <results_first_submitted_qc>April 14, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">May 10, 2021</results_first_posted>
  <last_update_submitted>May 9, 2021</last_update_submitted>
  <last_update_submitted_qc>May 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Dartmouth-Hitchcock Medical Center</investigator_affiliation>
    <investigator_full_name>Alan J. Budney</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Substance-Related Disorders</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>February 17, 2015</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/84/NCT02063984/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruited from a community intensive outpatient program from December 2015 to October 2017.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>CM + WMT</title>
          <description>Intensive Outpatient Treatment + Contingency Management + Working Memory Training (IOP + CM + WMT)</description>
        </group>
        <group group_id="P2">
          <title>CM + No WMT</title>
          <description>Intensive Outpatient Treatment + Contingency Management (IOP + CM)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="29"/>
                <participants group_id="P2" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
                <participants group_id="P2" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>CM + WMT</title>
          <description>Intensive Outpatient Treatment + Contingency Management + Working Memory Training (IOP + CM + WMT)</description>
        </group>
        <group group_id="B2">
          <title>CM + No WMT</title>
          <description>Intensive Outpatient Treatment + Contingency Management (IOP + CM)</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="29"/>
            <count group_id="B2" value="30"/>
            <count group_id="B3" value="59"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16.0" spread="1.5"/>
                    <measurement group_id="B2" value="16.7" spread="2.1"/>
                    <measurement group_id="B3" value="16.35" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="54"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="45"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Any Cannabis Abstinence</title>
        <description>Number of participants with any cannabis abstinence during treatment</description>
        <time_frame>Intervention weeks 1 to 14</time_frame>
        <population>Participants who met Cannabis Use Disorder criteria, excluding those who met other drug use disorder criteria.</population>
        <group_list>
          <group group_id="O1">
            <title>CM + WMT</title>
            <description>Intensive Outpatient Treatment + Contingency Management + Working Memory Training (IOP + CM + WMT)</description>
          </group>
          <group group_id="O2">
            <title>CM + No WMT</title>
            <description>Intensive Outpatient Treatment + Contingency Management (IOP + CM)</description>
          </group>
        </group_list>
        <measure>
          <title>Any Cannabis Abstinence</title>
          <description>Number of participants with any cannabis abstinence during treatment</description>
          <population>Participants who met Cannabis Use Disorder criteria, excluding those who met other drug use disorder criteria.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>CM+No WMT is the comparison condition</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>.42</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>.11</ci_lower_limit>
            <ci_upper_limit>1.56</ci_upper_limit>
            <estimate_desc>Outcome was tested in a zero-inflated negative binomial (ZINB) model</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Weeks of Continuous Cannabis Abstinence</title>
        <description>Weeks of continuous abstinence during treatment</description>
        <time_frame>14 week treatment period</time_frame>
        <population>Calculated only for those who achieved at least one week of abstinence during the treatment period</population>
        <group_list>
          <group group_id="O1">
            <title>CM + WMT</title>
            <description>Intensive Outpatient Treatment + Contingency Management + Working Memory Training (IOP + CM + WMT)</description>
          </group>
          <group group_id="O2">
            <title>CM + No WMT</title>
            <description>Intensive Outpatient Treatment + Contingency Management (IOP + CM)</description>
          </group>
        </group_list>
        <measure>
          <title>Weeks of Continuous Cannabis Abstinence</title>
          <description>Weeks of continuous abstinence during treatment</description>
          <population>Calculated only for those who achieved at least one week of abstinence during the treatment period</population>
          <units>Weeks of Continuous Abstinence</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.15" spread="4.63"/>
                    <measurement group_id="O2" value="4.88" spread="4.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>CM+No WMT is the comparison condition</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <param_type>Ratio of means</param_type>
            <param_value>1.56</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>.79</ci_lower_limit>
            <ci_upper_limit>3.07</ci_upper_limit>
            <estimate_desc>Outcome was tested in a zero-inflated negative binomial (ZINB) model</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Any Days of Cannabis Use</title>
        <description>Number of participants with any days of cannabis use during treatment</description>
        <time_frame>Intervention weeks 1 to 14</time_frame>
        <population>Participants with Cannabis Use Disorder and with non-missing data on 25% or more of treatment days (excluding those with other drug use disorder)</population>
        <group_list>
          <group group_id="O1">
            <title>CM + WMT</title>
            <description>Intensive Outpatient Treatment + Contingency Management + Working Memory Training (IOP + CM + WMT)</description>
          </group>
          <group group_id="O2">
            <title>CM + No WMT</title>
            <description>Intensive Outpatient Treatment + Contingency Management (IOP + CM)</description>
          </group>
        </group_list>
        <measure>
          <title>Any Days of Cannabis Use</title>
          <description>Number of participants with any days of cannabis use during treatment</description>
          <population>Participants with Cannabis Use Disorder and with non-missing data on 25% or more of treatment days (excluding those with other drug use disorder)</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>CM+No WMT is the comparison condition</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>.93</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>.18</ci_lower_limit>
            <ci_upper_limit>4.82</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Days of Cannabis Use</title>
        <description>Percent of Days Used During the Treatment Period</description>
        <time_frame>The intervention period between Week 1 and Week 14</time_frame>
        <group_list>
          <group group_id="O1">
            <title>CM + WMT</title>
            <description>Intensive Outpatient Treatment + Contingency Management + Working Memory Training (IOP + CM + WMT)</description>
          </group>
          <group group_id="O2">
            <title>CM + No WMT</title>
            <description>Intensive Outpatient Treatment + Contingency Management (IOP + CM)</description>
          </group>
        </group_list>
        <measure>
          <title>Days of Cannabis Use</title>
          <description>Percent of Days Used During the Treatment Period</description>
          <units>percentage of days of cannabis use</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.5" spread="31.0"/>
                    <measurement group_id="O2" value="24.5" spread="23.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>CM+No WMT is the comparison condition</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <param_type>Ratio of means</param_type>
            <param_value>.92</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>.33</ci_lower_limit>
            <ci_upper_limit>2.54</ci_upper_limit>
            <estimate_desc>Outcome was tested in a zero-inflated negative binomial (ZINB) model</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Any Cannabis Abstinence Across Four Treatment Strategies</title>
        <description>Number of participants who achieved at least one week of abstinence</description>
        <time_frame>Treatment period between week 1 and week 14</time_frame>
        <population>Ns in each strategy are the sum of [1] dropouts in the phase 1 condition, [2] responders in the phase 1 condition; and [3] nonresponders in the phase 1 condition who are assigned to the specified phase 2 condition. These ns for each strategy are: [1] 5+8+8=21; [2] 6+10+5=21; [3] 5+8+8=21; [4] 6+10+8=24.</population>
        <group_list>
          <group group_id="O1">
            <title>Strategy 1</title>
            <description>Start in CM stay in CM</description>
          </group>
          <group group_id="O2">
            <title>Strategy 2</title>
            <description>Start in CM+WMT stay in CM+WMT</description>
          </group>
          <group group_id="O3">
            <title>Strategy 3</title>
            <description>Start in CM responders stay in CM, non-responders get Enhanced CM</description>
          </group>
          <group group_id="O4">
            <title>Strategy 4</title>
            <description>Start in CM+WMT responders stay in CM+WMT, non-responders get Enhanced CM+WMT</description>
          </group>
        </group_list>
        <measure>
          <title>Any Cannabis Abstinence Across Four Treatment Strategies</title>
          <description>Number of participants who achieved at least one week of abstinence</description>
          <population>Ns in each strategy are the sum of [1] dropouts in the phase 1 condition, [2] responders in the phase 1 condition; and [3] nonresponders in the phase 1 condition who are assigned to the specified phase 2 condition. These ns for each strategy are: [1] 5+8+8=21; [2] 6+10+5=21; [3] 5+8+8=21; [4] 6+10+8=24.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="21"/>
                <count group_id="O3" value="21"/>
                <count group_id="O4" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="12"/>
                    <measurement group_id="O3" value="14"/>
                    <measurement group_id="O4" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Strategy 1 is the comparison condition</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>1.04</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>.45</ci_lower_limit>
            <ci_upper_limit>2.45</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Strategy 1 is the comparison condition</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>2.29</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>.84</ci_lower_limit>
            <ci_upper_limit>6.20</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Strategy 1 is the comparison condition</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>.51</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>.23</ci_lower_limit>
            <ci_upper_limit>1.13</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Weeks of Cannabis Abstinence Across Four Treatment Strategies</title>
        <description>Mean weeks of continuous cannabis abstinence among those who achieved at least one week of abstinence</description>
        <time_frame>Treatment period between week 1 and week 14</time_frame>
        <population>Participants with at least one week of cannabis abstinence during treatment</population>
        <group_list>
          <group group_id="O1">
            <title>Strategy 1</title>
            <description>Start in CM stay in CM</description>
          </group>
          <group group_id="O2">
            <title>Strategy 2</title>
            <description>Start in CM+WMT stay in CM+WMT</description>
          </group>
          <group group_id="O3">
            <title>Strategy 3</title>
            <description>Start in CM responders stay in CM, non-responders get Enhanced CM</description>
          </group>
          <group group_id="O4">
            <title>Strategy 4</title>
            <description>Start in CM+WMT responders stay in CM+WMT, non-responders get Enhanced CM+WMT</description>
          </group>
        </group_list>
        <measure>
          <title>Weeks of Cannabis Abstinence Across Four Treatment Strategies</title>
          <description>Mean weeks of continuous cannabis abstinence among those who achieved at least one week of abstinence</description>
          <population>Participants with at least one week of cannabis abstinence during treatment</population>
          <units>weeks of continuous abstinence</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
                <count group_id="O3" value="14"/>
                <count group_id="O4" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.17" spread="4.73"/>
                    <measurement group_id="O2" value="7.42" spread="4.74"/>
                    <measurement group_id="O3" value="5.29" spread="4.43"/>
                    <measurement group_id="O4" value="7.82" spread="4.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Strategy 1 is the comparison condition</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <param_type>Ratio of means</param_type>
            <param_value>1.21</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>.76</ci_lower_limit>
            <ci_upper_limit>1.92</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Strategy 1 is the comparison condition</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <param_type>Ratio of means</param_type>
            <param_value>.76</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>.49</ci_lower_limit>
            <ci_upper_limit>1.18</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Strategy 1 is the comparison condition</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <param_type>Ratio of means</param_type>
            <param_value>1.33</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>.83</ci_lower_limit>
            <ci_upper_limit>2.15</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Information will be collected from the scheduled first study visit through the 12 month follow-up assessment visit. (12 months total)</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Intensive Outpatient Treatment (IOP) + Contingency Management (CM) + Working Memory Training (WMT)</title>
          <description>IOP + CM + WMT&#xD;
Intensive Outpatient Treatment (IOP) + Contingency Management (CM): Multiple group sessions weekly, one individual counseling session weekly with teen to review and discuss contingency management abstinence-based incentives&#xD;
Working Memory Training: 25 computer-delivered sessions of neurocognitive training</description>
        </group>
        <group group_id="E2">
          <title>IOP + CM</title>
          <description>IOP + CM&#xD;
Intensive Outpatient Treatment (IOP) + Contingency Management (CM): Multiple group sessions weekly, one individual counseling session weekly with teen to review and discuss contingency management abstinence-based incentives</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="29"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="30"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="29"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="29"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="29"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Loss of consciousness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="29"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Overdose</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="29"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="30"/>
              </event>
              <event>
                <sub_title>Suicidal ideation without a plan</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="29"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="30"/>
              </event>
              <event>
                <sub_title>Suicide attempt</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="29"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="30"/>
              </event>
              <event>
                <sub_title>Drug induced psychosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="29"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Incarceration</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="29"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="30"/>
              </event>
              <event>
                <sub_title>Arrest</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="29"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Alan J. Budney, Ph.D</name_or_title>
      <organization>Geisel School of Medicine at Dartmouth Center for Technology and Behavioral Health</organization>
      <phone>603-646-7088</phone>
      <email>alan.budney@dartmouth.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

